HIV and AIDS Trial, Recruiting NCT07149259 Sponsor: Brooks Rehabilitation Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT07149259
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 90 years old.
  • People whose best vision (with glasses or contact lenses) falls between 20/50 and 20/400 in their better eye.
  • People who have been diagnosed with an eye condition that causes vision loss.
  • People who have a combined field of vision of at least 20 degrees across both eyes.
  • People whose vision has been stable for at least six months.
  • People who show some improvement in vision when magnification is used.
  • People who are willing to wear the eSight Go device in different settings, both at home and out in the community.
  • People who score 20 or above on a short memory and thinking test called the OMCT.
  • People who are able to give informed consent to participate.
  • People who agree to use the eSight device only in situations where it is safe to do so for both themselves and the device.

Who may not be able to join:

  • People who are currently having any medical or surgical treatment that is causing their vision to change or be unstable.
  • People who have had cataract surgery, laser eye surgery, or other eye-related surgery in the six months before joining the study.
  • People whose vision in their better eye is worse than 20/400.
  • People who score below 20 on the OMCT memory and thinking test.
  • People who have received eye injections (such as anti-VEGF injections) in the two months before joining, if those injections were given due to active bleeding in the retina. People receiving ongoing injections on a stable maintenance schedule where the retina is currently dry may still be considered eligible (confirm with trial site).
  • People who are unable or unwilling to attend scheduled appointments as required by the study, including those for whom travel to the study site is not manageable.
  • People who report a personal history of alcoholism, drug misuse, or psychosis.
  • People who show signs of depression, low motivation, emotional or intellectual difficulties, or any other condition that the investigator believes would affect their ability to participate appropriately or to give valid consent.
  • People who may have a conflict of interest with eSight Corp that could influence their involvement in the study.
  • People whose prescription is outside the range that the device's lens inserts can correct (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katelyn Jordan, D.O., Brooks Rehabilitation

Phone: 904-597-3478

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Brooks Rehabilitation
Registry
ClinicalTrials.gov
Start date
18 June 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Visual Acuity; Change in Reading Performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov